Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

December 27, 2019 00:23:35
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Critical Care Perspectives in Emergency Medicine
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Dec 27 2019 | 00:23:35

/

Show Notes

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

June 03, 2019 00:20:43
Episode Cover

Early Post-Cardiac Arrest Catheterization - The COACT Trial

A critical component to post-arrest care for the patient with ROSC following out-of-hospital cardiac arrest is early coronary angiography. Current guidelines recommend immediate cardiac...

Listen

Episode 0

October 21, 2022 00:18:32
Episode Cover

Does the Timing of Source Control in Sepsis Make a Difference?

The emergency department resuscitation of patients with sepsis focuses on early recognition, timely administration of appropriate antibiotics, appropriate fluid resuscitation, early vasopressor initiation for...

Listen

Episode 0

October 06, 2017 00:33:20
Episode Cover

Noninvasive Ventilation for the Emergency Physician

We know NIV works well for patients with acute COPD or acute CHF exacerbations.  In this episode we discuss the evidence for NIV not...

Listen